Total
0
Shares
Nextleaf Labs (CSE:OILS) receives sensory evaluation research license
Source: Nextleaf
  • Nextleaf Labs, a subsidiary of Nextleaf Solutions (OILS), has received an amendment to its existing Cannabis Research License from Health Canada
  • The amendment allows the company to conduct controlled human administration trials for the sensory evaluation of cannabis
  • Under the research license, Nextleaf Labs can begin comprehensively testing cannabis vape oils for key fluid parameters such as viscosity
  • The company said it plans to use this license to conduct controlled human trials for the sensory evaluation of Rapid Emulsion Technology by OILS
  • Nextleaf Solutions is up 11.48 per cent to C$0.34 per share

Nextleaf Labs, a subsidiary of Nextleaf Solutions (OILS), has received an amendment to its existing Cannabis Research License from Health Canada.

The amendment allows the company to conduct controlled human administration trials for the sensory evaluation of cannabis.

Nextleaf Labs will conduct the trials at its processing facility in Metro Vancouver.

The licence permits Nextleaf Labs to conduct R&D involving the administration of cannabis to human subjects for the assessment of taste, sight, or smell, subject to conditions laid out by Health Canada.

Nextleaf CEO Paul Pedersen said sensory evaluation with human subjects is essential to the development of differentiated cannabis 2.0 products.

"We believe this license provides added-value to consumer-packaged goods companies looking for product development and formulation capabilities within a federally legal market," Pederson said.

In a press release, the company said it plans to use this license to conduct controlled human trials for the sensory evaluation of Rapid Emulsion Technology by OILS, the company's proprietary water-soluble emulsion technology for cannabis infused products.

The license will allow the company to conduct focus-group studies to provide its commercial partners with data, based on consumer feedback around taste and overall user experience.

Under the research license, Nextleaf Labs can begin comprehensively testing cannabis vape oils for key fluid parameters such as viscosity, and how various oil formulations interact with different vape hardware to determine the best fit for each partners' formulations.

The company expects to drastically shorten design cycles and accelerate product development by validating new technologies and formulations more efficiently.

Nextleaf Solutions is up 11.48 per cent to C$0.34 per share at 2:22pm EST.


Subscribe


More From The Market Herald
Canbud (CSE:CBDX) launches plant-based protein brand

" Canbud (CSE:CBDX) launches plant-based protein brand

Canbud Distribution Corp. (CBDX) has launched a plant-based protein brand called Empathy Plant Co.™
Radient Technologies (TSXV:RTI) participates in medical cannabis study

" Nass Valley Gateway (CSE:NVG.CN) announces offering of 30 new products

Nass Valley Gateway (NVG.CN) is offering 30 new products, including an expanded pet menu.
Liposome structure cell 3D rendering - The Market Herald Canada

" Innocan Pharma (CSE:INNO) produces CBD loaded liposomes

Innocan Pharma Corp. (INNO) successfully produced CBD loaded liposomes under aseptic conditions.
Eguana Technologies (TSXV:EGT) releases 2020 annual results

" Aurora Cannabis (TSXV:ACB) announces US$125 million bought deal financing

Aurora Cannabis Inc. (ACB) pushes for a deal amounting to US$125 million through bought deal financing.